✦ LIBER ✦
Targeted IV busulfan and fludarabine followed by post-allogeneic hematopoietic cell transplantation rituximab demonstrate encouraging activity in CD20+ lymphoid malignancies without increased risk of infectious complications
✍ Scribed by Joseph Pidala; Jaime Roman-Diaz; Jongphil Kim; Taiga Nishihori; Janelle Perkins; Cheryl Tate; Jose L. Ochoa-Bayona; Teresa Field; Hugo F. Fernandez; Marcie Tomblyn; Ernesto Ayala; Claudio Anasetti; Mohamed A. Kharfan-Dabaja
- Book ID
- 107619193
- Publisher
- Carden Jennings Publishing
- Year
- 2011
- Tongue
- English
- Weight
- 271 KB
- Volume
- 93
- Category
- Article
- ISSN
- 0925-5710
No coin nor oath required. For personal study only.